Any piperazine carrying one or more hydroxy substituents.
ChEBI ID: 71633
| Member | Definition | Role |
|---|---|---|
| favipiravir | A member of the class of pyrazines that is pyrazine substituted by aminocarbonyl, hydroxy and fluoro groups at positions 2, 3 and 6, respectively. It is an anti-viral agent that inhibits RNA-dependent RNA polymerase of several RNA viruses and is approved for the treatment of influenza in Japan. | favipiravir |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (2.37) | 29.6817 |
| 2010's | 162 (27.46) | 24.3611 |
| 2020's | 414 (70.17) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 47 (7.77%) | 5.53% |
| Reviews | 103 (17.02%) | 6.00% |
| Case Studies | 61 (10.08%) | 4.05% |
| Observational | 12 (1.98%) | 0.25% |
| Other | 382 (63.14%) | 84.16% |